Johnson & Johnson vaccine reports good results
Said to protect 66% moderate to severe infections January 29, 2021 82 An illustration shows vials with COVID-19 vaccine stickers attached and syringes with the logo of US pharmaceutical company Johnson & Johnson on Nov. 17, 2020. In a large, late-stage trial the Johnson & Johnson one-shot vaccine prevented 66% of moderate to severe cases of COVID-19. (Justin Tallis/AFP/Getty Images/TNS) Johnson & Johnson’s one-shot vaccine generated strong protection against COVID-19 in a large, late-stage tr...
Source: rep-am.com